429 related articles for article (PubMed ID: 16623608)
1. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.
Bramley TJ; Gerbino PP; Nightengale BS; Frech-Tamas F
J Manag Care Pharm; 2006 Apr; 12(3):239-45. PubMed ID: 16623608
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes.
Andros V; Egger A; Dua U
J Manag Care Pharm; 2006 May; 12(4):303-9. PubMed ID: 16792436
[TBL] [Abstract][Full Text] [Related]
3. Assessment of drug therapy management and the prevalence of heart failure in a managed care population with hypertension.
Jackson JH; Frech F; Ronen R; Mullany L; Lennert B; Jhaveri V
J Manag Care Pharm; 2004; 10(6):513-20. PubMed ID: 15548123
[TBL] [Abstract][Full Text] [Related]
4. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
5. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
[TBL] [Abstract][Full Text] [Related]
6. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
7. Assessing medication consultations, hypertension control, awareness, and treatment among elderly Asian community dwellers.
Lam AY
Consult Pharm; 2008 Oct; 23(10):795-803. PubMed ID: 19032015
[TBL] [Abstract][Full Text] [Related]
8. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
[TBL] [Abstract][Full Text] [Related]
9. Treatment Patterns and Blood Pressure Control With Initiation of Combination Versus Monotherapy Antihypertensive Regimens.
An J; Luong T; Qian L; Wei R; Liu R; Muntner P; Brettler J; Jaffe MG; Moran AE; Reynolds K
Hypertension; 2021 Jan; 77(1):103-113. PubMed ID: 33190560
[TBL] [Abstract][Full Text] [Related]
10. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
Jing S; Naliboff A; Kaufman MB; Choy M
J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
[TBL] [Abstract][Full Text] [Related]
11. Assessment of factors influencing blood pressure control in a managed care population.
Romain TM; Patel RP; Heaberlin AM; Zarowitz BJ
Pharmacotherapy; 2003 Aug; 23(8):1060-70. PubMed ID: 12921252
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertension in a managed care setting.
DiTusa L; Luzier AB; Jarosz DE; Snyder BD; Izzo JL
Am J Manag Care; 2001 May; 7(5):520-4. PubMed ID: 11388131
[TBL] [Abstract][Full Text] [Related]
13. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization.
Cooke CE; Fatodu H
J Manag Care Pharm; 2006 Oct; 12(8):649-55. PubMed ID: 17269843
[TBL] [Abstract][Full Text] [Related]
14. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive medication changes and blood pressure goal achievement in a managed care population.
Engel-Nitz NM; Darkow T; Lau H
J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489
[TBL] [Abstract][Full Text] [Related]
17. Improving hypertension care in a large group-model MCO.
Godley P; Nguyen A; Yokoyama K; Rohack J; Woodward B; Chiang T
Am J Health Syst Pharm; 2003 Mar; 60(6):554-64. PubMed ID: 12659057
[TBL] [Abstract][Full Text] [Related]
18. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
19. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.
Wang Z; Chen Z; Zhang L; Wang X; Hao G; Zhang Z; Shao L; Tian Y; Dong Y; Zheng C; Wang J; Zhu M; Weintraub WS; Gao R;
Circulation; 2018 May; 137(22):2344-2356. PubMed ID: 29449338
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking and severe uncontrolled hypertension in inner-city African Americans.
McNagny SE; Ahluwalia JS; Clark WS; Resnicow KA
Am J Med; 1997 Aug; 103(2):121-7. PubMed ID: 9274895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
